What Happens Next for Moderna's and Pfizer's Coronavirus Vaccine Candidates

Adria Cimino, The Motley Fool
·4 min read
What Happens Next for Moderna's and Pfizer's Coronavirus Vaccine Candidates

December will be a crucial month for both Moderna (NASDAQ: MRNA) and Pfizer (NYSE: PFE). Earlier this week, Moderna requested Emergency Use Authorization (EUA) for its coronavirus vaccine candidate. Pfizer and its partner BioNTech (NASDAQ: BNTX) made their request about ten days earlier.